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Abstract
Here we focus on Fat’s Big Bang exploring o!cially by the discovery of leptin by 
Je"rey Friedman and colleagues on 1 December 1994 in Nature. We recall their 
journey of discovery and discuss perspective on the further research in adipobi-
ology and adipopharmacology of cardiometabolic, neuropsychiatric and cancer 
diseases. Friedman’s seminal discovery makes a paradigm shift in our knowledge 
of adipose tissue biology - from merely a fat storage and metabolizer to a major 
endocrine and paracrine organ of the human body, producing more than 600 
signaling proteins collectively termed adipokines. Leptin thus became the 
fundament in the obesity research and related diseases. 
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e new paradigm should always 
be  better, not just di!erent.
omas Kuhn, e Structure 
of Scienti"c Revolutions, 1962
More than 20 centuries ago in his poem 
De rerum natura (On the Nature of 
!ings, or On the Nature of the Uni-
verse) Titus Lucretius (c. 99 BC – c. 55 
BC), a Roman poet and philosopher, 
described “Universum” as operating ac-
cording to physical principles, guided by 
fortuna, “chance”. !e latter supposedly 
managed a scenario of the Big Bang that 
explored about 14 billion years ago with 
a superhot universal dance of quarks, 
protons, neutrons. And leptons (light 
particles; Greek leptos – thin, slim), the 
dance leading to the formation of all gal-
axies composed of stars, planets, comets, 
meteors, asteroids, quasars, black holes, 
all “rotating as one.” And “the universe 
suddenly became boundless as hope” as 
in Jorge Luis Borges’ Library of Babel.
Four billion years ago Cell’s Big Bang 
has occurred - the birth of a single cell 
compartmentalized by phospholipid 
bilayer. Natura non facit saltus (Nature 
does not make leaps) – a saying attrib-
uted to Carl Linnaeus (1707 – 1778), 
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Swedish botanist and physician, “father of modern taxonomy” 
who introduced the system of naming organisms in his book 
Systema Naturae, the !rst edition being published in 1735. 
Gradually, about 800 million years ago, the !rst multicellular 
organisms arose, !sh, reptiles, birds, monkeys, man - Homo ha-
bilis (the skilled person) le" Africa, migrated to Europe, became 
Homo sapiens recens.
Forty-!"y thousand years ago occurs Brain’s Big Bang - in-
creases gray matter of the brain, appear smart genes that help peo-
ple to remember, to think logically and abstractly, to understand 
other people - his thinking, feelings, behavior. “We are not think-
ing beings, we are emotional creatures who think” - summed up in 
1994 Antonio Damazio in his book Descartes’ Error and by Danilo 
Mainardi in his text !e Cultural Animal.
Fat’s Big Bang: the discovery of leptin
#e descriptions of ob/ob (obese) mice in 1950 and db/db (dia-
betic) mice in 1966 have established that the ob/ob mouse lacked 
a circulating factor to which the db/db mouse was resistant. It 
was Douglas Coleman who presented the hypothesis of “satiety 
hormone” in the 1970s when working in Jackson Laboratory, Bar 
Harbor, Maine, the largest reserve of obese and diabetic mice 
(see 4). Hundreds of them were transferred to the Laboratory of 
Je$rey Friedman at Rockefeller University. For their work lead-
ing to the discovery of leptin, an adipocyte-secreted hormone, 
Je$rey Friedman and Douglas Coleman received the 2009 Shaw 
Prize in Life Science and Medicine, known as Nobel Prize of the 
Far East. And the Albert Lasker  Prize, a Nobel Prize of America. 
Je$rey M. Friedman was born in Orlando, Florida, USA on 
July 20, 1954, and received his MD at the age of 22. “As a doctor, 
you’re trained to absorb the facts you’re given and accept them. 
Science is almost the opposite. It’s a frontier of discovery that’s 
always moving. And I decided I wanted to do research” - says 
Friedman. He started his a%liation with the Rockefeller Univer-
sity in 1980, where he was awarded a PhD degree in 1986.  His 
research curiosity led him to pursue a !eld related to the ob gene 
in mice, a search that took 8 years. And in 1994 resulting in the 
discovery of a very talented cytokine/hormone secreted by adi-
pocytes, now known as leptin (1) (Box 1). 
Leptin functions as an a$erent signal in a negative feedback 
loop that regulates food intake and energy homeostasis to main-
tain control of adipose tissue mass. From the adipocytes leptin 
is exported into the blood circulation, enters the brain and 
stimulates anorexogenic and inhibits orexogenic neurons (Table 
1), the arcuate nucleus, paraventricular nucleus, dorsomedial 
nucleus, ventromedial nucleus and lateral hypothalamic area 
being the brain leptin sensitive hub. #e net e$ect of these ac-
tions is satiety, stop eating. When mice leptin gene is deleted, 
knockout mice (ob/ob mice), or the gene for leptin receptor (db/
db mice) is deleted, the mice eat without !lling of satiety, thus 
becoming obese and diabetic respectively (1-7). 
    Since the Fat’s Big Bang explored o%cially on 1 December 
1994, onwards until December 5, 2015 leptin appeared in 29 
032 scienti!c articles (according to PubMed, National Library 
of Medicine, USA) and participated in more than 50 inter-
national symposia, including four International Symposia on 
Adipobiology and Adipopharmacology (ISAA), the 4the ISAA 
being held on 28 - 31 October 2015 in Bucharest, Romania (see 
selected abstracts in this volume of Adipobiology). #e 5th ISAA 
will be held in Mexico City, Mexico in 2018 organized by Mar-
cia Hiriart, Head, Instituto de Fisiologia Celular, Universidad 
Nacional Autonoma de Mexico, Mexico D.F., Mexico.
#e discovery of leptin shi"s the adipose tissue paradigm 
from merely a fat storage, the tissue is now known as a major 
endocrine and paracrine organ of the human body, producing 
more than 600 signaling proteins (adipokines) (8). Bulgarian 
and Italian scientists also actively participate in the action of 
Fat’s Big Bang conceptualizing two new !elds of research desig-
nated adipobiology and adipopharmacology (9, 10; Box 2).
Onward, it is demonstrated that adipose tissue is able to send 
and receive di$erent types of protein and non-protein signals, 
thus communicating with many organs in the body. And, in e$ect, 
contributing to the control of lipid and glucose metabolism, 
in&ammation, immunity, reproduction, hemostasis, vascular 
smooth muscle contraction-relaxation, learning, memory, 
emotions among many other biological functions. #us in the 
last 21 years, that is, the time a"er Friedman’s discovery of 
leptin, the adipose tissue horizon rises to take center stage in so 
many diseases that it leaves most scientists and medical doctors 
astonished. Associated with leptin discovery/ ”rediscovery” of 
adipose tissue, the studies of cardiometabolic, neuropsychiatric, 
liver and lung  diseases have increasingly emerged (11-42; Table 
2). For diabetes-Alzheimer link, see Aloe et al in this volume of 
Adipobiology. 
In a 2012 interview with Je$rey Friedman (7), to the ques-
tions “More recently, you have been studying how leptin a$ects 
neuronal plasticity. Can you tell us about this? Your lab is work-
ing on several projects. What are you most excited about at the 
moment?”, Friedman replies: “Leptin changes the types and pat-
terns of connections among neurons... One of the main projects 
in the lab is delineating the neural circuitry that regulates food 
intake and body weight.  I think that understanding the molecu-
lar and cellular basis of making behavioural decisions is going 
to be a very important and exciting area for future research. To 
develop drugs that normalize weight will be a more di%cult task 
moving forward, but I am optimistic that safe molecules that 
reduce weight enough to improve diabetes, hypertension and 
other complications associated with obesity will be developed.” 
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Box 1. Curriculum Vitae of Leptin
Name: Leptin, 16 kD, 167 amino acids
Gene: Obese (ob, Lep), Chromosome 7q31.3
Receptors: Ob-R (LEP-R, CD295), db gene splicing products 
LEP-R
L 
(LEP-Rb, long form of the leptin receptor, containing a 
302–amino acid cytoplasmic domain)
LEP-R
S
 (LEP-Ra, c, d, e, and f, OB-R short forms, containing a 
34–amino acid cytoplasmic domain) 
Megalin (gp600/LRP2)
Born o!cially: 1 December 1994 in Nature 1994; 372: 425-432.
O!cial birth place: Laboratory of Molecular Genetics, The 
Rockefeller University
York Avenue, between 63rd and 68th Streets, the Upper East 
Side of Manhattan, New York City, NY, USA
Natural birth place: adipocytes
Other birth places: gastric epithelial cells, cardiomyocytes, 
interstitial lung perialveolar !broblasts, ovaries, bone marrow, 
placenta, lymphocytes, mast cells, macrophages, liver 
perisinusoidal  lipid storage cells (Ito cells, hepatic stellate cells)… 
Functions: food intake, energy balance, cell growth, 
reproduction, immunity, hemostasis, angiogenesis, collagen 
!brogenesis, osteogenesis, neuroprotection, neuronal 
plasticity, mood…
Box 2. Lingua  Adipobiologica – de!nition of terms
Adipobiology – study of molecular and cell biology of adipose 
tissue in health and disease
Adipokines – adipose cells-secreted signaling proteins
Adipokinome – proteome of adipokines
Adipopharmacology  – adipose tissue-targeted studies for 
drug discovery
Adipocrinology - a component of endocrinology
    - Adipoendocrinology
    - Adipoparacrinology
Neuroadipocrinology –  a component of neuroendocrinology
Adipoimmunology – study of the role of adipose tissue-
associated immune cells
Adipotoxicology – study the accumulation and metabolism of 
xenobiotics in adipose tissue
Tunica adiposa – the outermost coat of the wall of blood vessels
Homo obesus – man obese
Homo diabesus – man with diabetes and obesity
Triactome – neuro-immune-adipose interactions
Table 1. Examples of neuromediators in leptin signaling in 
the brain, controlling food intake*
Anorexigenic pathway Orexigenic pathway
Proopiomelanocortins
Melanocortin 4    





* For brain dopaminergic circuit in the motivational behavior in 
“how do we decide to eat or do not eat?”, see (3, 4, 7). Also (6) for 
amylin-leptin interaction in contoling food intake.
Table 2. A selected list of leptin-related diseases and 
symptomes
Obesity, Anorexia nervosa, Bulimia nervosa
Atherosclerosis, Hypertension, Metabolic syndrome, Type 2 
diabetes mellitus
Obstructive sleep apnea, Polycystic ovary syndrome
Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, 
Liver cirrhosis
Osteoporosis, Rheumatoid arthritis, Cancers, Cachexia
Bronchial asthma, Chronic obstructive pulmonary disease 
Alzheimer’s disease, Depression, Schizophrenia
Leptin de!ciency syndromes
Congenital generalized, acquired generalized lipodystrophy*
Hypothalamic amenorrhea, delayed onset of puberty
Immune abnormalities leading to an increased susceptibility to 
infectious disease
Type 1 diabetes mellitus
*On 24 February, 2014, the USA Food and Drug Administration 
approved Myalept (metreleptin for injection) as replacement 
therapy to treat the complications of leptin de!ciency in patients 
with these lipodystrophies (see 4).
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Post scriptum
Dear Dr Chaldakov and Colleagues,    
anks to you for what I believe to be the only birthday party 
celebrating the anniversary of the cloning of the ob gene. I had 
forgotten entirely that this milestone was about to pass and am 
grateful to you all for bringing this to my attention. I will now 
have to organize a party here as well. It is hard to believe so much 
time has passed. I hope you have a productive and illuminating 






We express our appreciations to the contributions of ob/ob mice 
to the development of research in adipobiology.
Conict of interest: e authors declare no con"ict of interest. 
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